N

Natera

D
NTRA
USD
5.925
(4.7636%)
Market Closed
27,142.00
Volume
-2.4265
EPS
-
Div Yield
-53.403689
P/E
16,116,308,996.76
Market Cap
Today
2.6185%
1 Week
7.752%
1 Month
1.531%
6 Months
34.031%
12 Months
198.454%
Year To Date
108.088%
All Time
0%

Title:
Natera

Sector:
Healthcare
Industry:
Diagnostics & Research
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
Do you need help or have a question?